Comparative study of a novel selective urate reabsorption inhibitor “dotinurad” among patient groups with different stages of renal dysfunction

BACKGROUND: Dotinurad is a selective urate reabsorption inhibitor (SURI), which selectively inhibits URAT1 to lower serum uric acid levels in patients with hyperuricemia. Herein, the effects of dotinurad were compared among patient groups with different stages of renal dysfunction. METHODS: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Toshinari, Beppu, Takanobu, Hidaka, Yuji, Hosoya, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526486/
https://www.ncbi.nlm.nih.gov/pubmed/34328574
http://dx.doi.org/10.1007/s10157-021-02115-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526486/
https://www.ncbi.nlm.nih.gov/pubmed/34328574
http://dx.doi.org/10.1007/s10157-021-02115-7

Ejemplares similares